Covid-19 vaccine Sputnik V phase 2/3 trial finally allowed- Drug controller General of India

Story by Rakesh Bind 11 months ago

Drug Controller General of India has finally allowed Dr. Reddy's to conduct phase 2/3 clinical human trial of Sputnik V. At present; Sputnik V is currently undergoing post-registration phase 3 clinical trial engaging 40,000 participants. As part of the partnership to conduct clinical trials, India will get 10 crore doses of Sputnik.

Read more at Hindustan Times

Stay informed

*Subscribe to our newsletter to receive early discount offers, updates and new products info.


Popular tags

#Ssr #ipl #covid19 #Arnab
Menu Saved